Doximity, Inc. (DOCS) stock analysis

Healthcare · Health Information Services

From the 10-K filed 2026-05-19

Business type: Franchise

How it makes money

Pharmaceutical manufacturers and health systems pay for marketing, hiring, and workflow solutions, driving strong revenue growth and high profitability.

Pharmaceutical manufacturers and health systems pay for commercial access to a network of verified medical professionals through Marketing Solutions, Hiring Solutions, and Workflow Solutions. These customers spend to reach physicians for brand goals, digital recruiting, and clinical productivity.

Revenue grew to $644.9 million for the fiscal year ended March 31, 2026, compared to $570.4 million and $475.4 million in the prior fiscal years, representing year-over-year growth rates of 13% and 20%. Net income reached $196.1 million, $223.2 million, and $147.6 million across those same three fiscal periods.

What protects it: the moat

Management claims that proprietary data combined with custom algorithms creates unique insights that are highly challenging for competitors to replicate.

The company relies on its vast interactive data set, combining proprietary information and siloed public information, to build insights into U.S. medical professionals. Management states that this foundation, alongside customized algorithms and clinical experts, creates a barrier that would be time-consuming for competitors to copy.

At the same time, the platform benefits from network effects as medical professional engagement expands with the breadth and utility of its tools, drawing more members and facilitating communication across the healthcare community.

What growth costs

Growth requires expanding full-time equivalent headcount, which increased from 830 to 880 personnel to support expanding operations.

The filing notes that full-time equivalent headcount increased from 830 as of March 31, 2025 to 880 as of March 31, 2026. This personnel expansion adds operational complexity and places strain on management, internal systems, financial resources, and reporting functions.

What could damage it

Concentrated revenue dependence on a small group of key customers could slow growth or reduce revenue if those accounts fail to renew.

Revenue is concentrated within a small number of key customers, primarily major pharmaceutical manufacturers and health systems. If these key customers reduce discretionary marketing spend, fail to renew subscriptions, or negotiate less favorable terms, the resulting drop in demand would directly impair the top-line earnings generated by Marketing and Workflow Solutions.

About Doximity, Inc.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Other companies in Health Information Services